Click here to view the United Healthcare (UHC) Medical Policy Updates » December 2024 United…
Aetna January 2018 Medical Policy Updates
Click here to view the Aetna Medical Policy Updates »
January 2018
New:
- January 2, 2018 – 0924 – Axicabtagene Ciloleucel (Yescarta)
Revised:
- January 17, 2018 – 0016 – Back Pain – Invasive Procedures
- January 17, 2018 – 0115 – Varicella and Herpes Zoster Vaccines
- January 17, 2018 – 0227 – BRCA Testing, Prophylactic Mastectomy, and Prophylactic Oophorectomy
- January 17, 2018 – 0322 – Electroencephalographic (EEG) Video Monitoring
- January 17, 2018 – 0352 – Tumor Markers
- January 17, 2018 – 0591 – Intervertebral Disc Prostheses
- January 17, 2018 – 0743 – Spinal Surgery: Laminectomy and Fusion
- January 17, 2018 – 0890 – Pembrolizumab (Keytruda)
- January 5, 2018 – 0404 – Interferons
- January 5, 2018 – 0654 – Ventricular Assist Devices
- January 5, 2018 – 0677 – Functional Electrical Stimulation and Neuromuscular Electrical Stimulation
- January 5, 2018 – 0878 – Naltrexone Implants
- January 5, 2018 – 0879 – Quantitative Pupillometry/Pupillography
- January 5, 2018 – 0880 – Percutaneous Mitral Valve Repair
- January 5, 2018 – 0881 – Canakinumab (Ilaris)
- January 5, 2018 – 0882 – Metreleptin (Myalept)
- January 5, 2018 – 0883 – Ramucirumab (Cyramza)
- January 5, 2018 – 0884 – Siltuximab (Sylvant)
- January 5, 2018 – 0885 – Vedolizumab (Entyvio)
- January 5, 2018 – 0886 – Optical Coherence Tomography and Microelastography for Solid Tumors and Other Selected Indications
- January 5, 2018 – 0887 – Belinostat (Beleodaq)
- January 5, 2018 – 0888 – Radiostereometric Analysis for Migration and Wear of Orthopedic Implants
- January 5, 2018 – 0889 – Levoleucovorin (Fusilev)
- January 5, 2018 – 0891 – Blinatumomab (Blincyto)
- January 5, 2018 – 0893 – Leadless Cardiac Pacemaker
- January 5, 2018 – 0894 – Recombinant Human Parathyroid Hormone (Natpara)
- January 5, 2018 – 0895 – Dinutuximab (Unituxin)
- January 5, 2018 – 0897 – Mepolizumab (Nucala)
- January 5, 2018 – 0899 – Elotuzumab (Empliciti)
- January 5, 2018 – 0900 – Talimogene Laherparepvec (Imlygic)
- January 5, 2018 – 0902 – Irinotecan Liposome Injection (Onivyde)
- January 5, 2018 – 0903 – Trabectedin (Yondelis)
- January 5, 2018 – 0904 – Daratumumab (Darzalex)
- January 5, 2018 – 0907 – Reslizumab (Cinqair)
- January 5, 2018 – 0908 – Vincristine Sulfate Liposome Injection (Marqibo)
- January 5, 2018 – 0909 – Atezolizumab (Tecentriq)
- January 5, 2018 – 0912 – Ustekinumab (Stelara)
- January 5, 2018 – 0913 – Olaratumab (Lartruvo)
- January 2, 2018 – 0206 – Parenteral Immunoglobulins
- January 2, 2018 – 0264 – Multiple Sclerosis
- January 2, 2018 – 0314 – Rituximab (Rituxan)
- January 2, 2018 – 0658 – Psoriasis and Psoriatic Arthritis: Targeted Immune Modulators
- January 2, 2018 – 0751 – Natalizumab (Tysabri)
- January 2, 2018 – 0790 – Golimumab (Simponi and Simponi Aria)
- January 2, 2018 – 0905 – Secukinumab (Cosentyx)
Updated:
- January 19, 2018 – 0008 – Color-Flow Doppler Echocardiography in Adults
- January 19, 2018 – 0365 – Pancreaticoduodenectomy (Whipple Resection)
- January 19, 2018 – 0592 – Radiofrequency Ablation of Hypertrophied Nasal Turbinates
- January 19, 2018 – 0593 – Aerosolized or Irrigated Anti-infectives for Sinusitis
- January 19, 2018 – 0597 – Heart-Lung Transplantation
- January 17, 2018 – 0315 – Enbrel (Etanercept)
- January 2, 2018 – 0341 – Infliximab
- January 2, 2018 – 0595 – Anakinra (Kineret)
- January 2, 2018 – 0655 – Adalimumab (Humira)
- January 2, 2018 – 0720 – Abatacept (Orencia)
- January 2, 2018 – 0761 – Certolizumab Pegol (Cimzia)
- January 2, 2018 – 0799 – Tocilizumab (Actemra)
- January 2, 2018 – 0839 – Tofacitinib (Xeljanz)
Click here to view the Aetna Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!
Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.